U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX13990177: GSM5848735: WT luminal, BM1, RNA-seq; Mus musculus; RNA-Seq
1 ILLUMINA (NextSeq 500) run: 8M spots, 664.1M bases, 249Mb downloads

External Id: GSM5848735_r1
Submitted by: Weizmann Institute of Science
Study: Breast cancer plasticity is restrictedby a LATS1-NCOR1 repressive axis [MARS-seq]
show Abstracthide Abstract
The tumor suppressor LATS1, whose expression is often downregulated in human breast cancer, helps maintain luminal breast cancer cell identity by keeping basal-specific genes in a closed chromatin state, preventing their spurious activation. This is achieved via interaction of LATS1 with the NCOR1 nuclear corepressor and recruitment of HDAC1,driving histone H3K27 deacetylation near NCOR1-repressed “basal” genes. Consequently, decreased expression of LATS1 elevates the expression of such “basal” genes and promotes luminal-to-basal slippage. Overall design: 4 samples X 2 replicates = 8 samples total
Sample: WT luminal, BM1, RNA-seq
SAMN25419881 • SRS11829652 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM5848735
Instrument: NextSeq 500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: RNA was isolated using the NucleoSpin kit (Macherey Nagel) 30ng of input RNA from each sample was barcoded during reverse transcription and pooled. Following Agencourt AMPure XP beads cleanup (Beckman Coulter), the pooled samples underwent second strand synthesis and were linearly amplified by T7 in vitro transcription. The resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with Illumina sequences during ligation, RT and PCR. MARS-seq
Runs: 1 run, 8M spots, 664.1M bases, 249Mb
Run# of Spots# of BasesSizePublished
SRR178284428,001,596664.1M249Mb2022-10-19

ID:
19617311

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...